IDEX Biometrics ASA
IDXAF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.00 | 0.00 | -0.01 |
| FCF Yield | -2,494.59% | -342.87% | -1,996.09% | -44.76% |
| EV / EBITDA | -0.46 | -0.97 | -1.66 | 4.24 |
| Quality | ||||
| ROIC | -72.51% | -51.37% | -50.24% | -32.13% |
| Gross Margin | 29.63% | -970.19% | -9,875.26% | -2,423.33% |
| Cash Conversion Ratio | 0.71 | 0.65 | 1.65 | -1.68 |
| Growth | ||||
| Revenue 3-Year CAGR | -61.18% | -48.89% | -41.31% | -29.88% |
| Free Cash Flow Growth | 47.71% | 17.86% | -50.32% | 54.21% |
| Safety | ||||
| Net Debt / EBITDA | -0.43 | -0.76 | -1.42 | 1.05 |
| Interest Coverage | -45.45 | -11.84 | -17.33 | -6.97 |
| Efficiency | ||||
| Inventory Turnover | 0.01 | 0.21 | 0.42 | 0.24 |
| Cash Conversion Cycle | 6,827.95 | 1,229.50 | 3,781.02 | 3,046.95 |